Program

Morning plenary

10:00 – 10:15 Welcome by MEDVIA & BioWin

Keynote session

10:15 – 10:45 Advances in (digital) technology

• Visionary keynote presentation: approach the topic from a technology perspective.

• Example of how a specific cutting-edge technology (e.g. AI in biophotonics) can be applied in the discovery and development of innovative treatment and prevention platforms.

Showcasing Innovative Treatment And Prevention Platforms

• Focus on a specific modality of strategic importance

• Including technology playing a crucial role in its discovery and/or development, e.g.: biomarkers & diagnostics, manufacturing, …

10:45 – 11:15 Innovative treatment/prevention platform 1

11:15 – 11:45 Innovative treatment/prevention platform 2

11:45 – 12:15 Innovative treatment/prevention platform 3

12:15 – 13:30 Networking lunch, in exhibition room (space for relevant academia, biotech and healthtech innovators)

Afternoon breakout sessions

TRACK 1
Biopharmaceutical engineering / manufacturing

13:30 – 13:55 Example case

13:55 – 14:20 Example case

TRACK 2
(Digital) technology / diagnostic tools (biomarkers)

13:30 – 13:55 Example case

13:55 – 14:20 Example case

14:20 – 14:50 Coffee break

Afternoon plenary

Keynote session

14:50 – 15:20 The factory of the future

• A high-level overview of the innovative approaches to produce the next generation of biopharmaceuticals

Round Table

15:20 – 16:20 Creating a roadmap: what is needed to make Belgium a leading region?

• Panel discussion on how to seize opportunities and address challenges

Closing Keynote

16:20 – 16:50 – Title

• Visionary speaker on biopharma ecosystem building, innovative technologies, patient involvement/funding new

treatment platforms, reality check: how are things happening in the hospital

16:50 – 17:00 Closing and invite for reception (MEDVIA & Biowin)

Science for health is a joint organisation from

With the support of following partners

Stay up-to-date

Sign up for our newsletter and be the first to receive information on our next edition.

Contact